These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19799086)

  • 21. JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression.
    Pahore ZA; Shamsi TS; Taj M; Farzana T; Ansari SH; Nadeem M; Ahmad M; Naz A
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):472-5. PubMed ID: 21798133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term results of the UHKT-911 study of adult patients under 65 years of age with de novo acute myeloid leukemias without favorable karyotypes].
    Lemez P; Vítek A; Michalová K; Zemanová Z; Lukásová M
    Vnitr Lek; 2003 Mar; 49(3):174-80. PubMed ID: 12728590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
    Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
    J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A quantitative assay for JAK2 mutation in 135 patients with chronic myeloproliferative neoplasms].
    Chao HY; Shen YM; Zhang R; Feng YF; Cen JN; Yao L; Shen HJ; Zhu ZL; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):321-5. PubMed ID: 19799128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
    Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of micromegakaryocytes in de novo AML].
    Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
    Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia.
    Zhong L; Jia YQ; Meng WT; Ni X
    Arch Pathol Lab Med; 2012 Jan; 136(1):84-9. PubMed ID: 22208491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
    Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
    Kuriyama K
    Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemia.
    Inokuchi K; Yamaguchi H; Hanawa H; Tanosaki S; Nakamura K; Tarusawa M; Miyake K; Shimada T; Dan K
    Clin Cancer Res; 2002 Jun; 8(6):1882-8. PubMed ID: 12060632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.
    Bloomfield CD; Shuma C; Regal L; Philip PP; Hossfeld DK; Hagemeijer AM; Garson OM; Peterson BA; Sakurai M; Alimena G; Berger R; Rowley JD; Ruutu T; Mitelman F; Dewald GW; Swansbury J
    Cancer; 1997 Dec; 80(11 Suppl):2191-8. PubMed ID: 9395033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The JAK2 V617F mutation in de novo acute myelogenous leukemias.
    Lee JW; Kim YG; Soung YH; Han KJ; Kim SY; Rhim HS; Min WS; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2006 Mar; 25(9):1434-6. PubMed ID: 16247455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 7].
    Lemez P; Gáliková J; Michalová K; Dvoráková D; MacWhannell A; Zemanová Z; Stejskal J
    Vnitr Lek; 2010 Jan; 56(1):37-43. PubMed ID: 20184110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlates of JAK2V617F allele burden in essential thrombocythemia.
    Kittur J; Knudson RA; Lasho TL; Finke CM; Gangat N; Wolanskyj AP; Li CY; Wu W; Ketterling RP; Pardanani A; Tefferi A
    Cancer; 2007 Jun; 109(11):2279-84. PubMed ID: 17440984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAK2V617F mutations in myeloid malignancies: single center experience.
    Panovska-Stavridis I; Cevreska L; Ivanovski M; Stojanovik A; Lozance M; Matevska N; Dimovski A; Serafimoski V
    Prilozi; 2008 Dec; 29(2):257-67. PubMed ID: 19259051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of three JAK2V617F mutation detection methods.
    Frantz C; Sekora DM; Henley DC; Huang CK; Pan Q; Quigley NB; Gorman E; Hubbard RA; Mirza I
    Am J Clin Pathol; 2007 Nov; 128(5):865-74. PubMed ID: 17951211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fully automated and super-rapid system for the detection of JAK2V617F mutation.
    Tanaka R; Kuroda J; Stevenson W; Ashihara E; Ishikawa T; Taki T; Kobayashi Y; Kamitsuji Y; Kawata E; Takeuchi M; Murotani Y; Yokota A; Hirai M; Majima S; Taniwaki M; Maekawa T; Kimura S
    Leuk Res; 2008 Sep; 32(9):1462-7. PubMed ID: 18328559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.